Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Virgil T. Gaddy"'
Autor:
Patricia V. Schoenlein, John T. Barrett, Sylvia B. Smith, Jim Rawson, Darren Browning, Marlena J. Smith, Manish Shah, Sudharsan Periyasamy Thandavan, Jennifer Duplantier, Virgil T. Gaddy, Julia S. Samaddar
This study identifies macroautophagy as a key mechanism of cell survival in estrogen receptor–positive (ER+) breast cancer cells undergoing treatment with 4-hydroxytamoxifen (4-OHT). This selective ER modifier is an active metabolite of tamoxifen c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::318291148195291f5e3ed5f1229c4451
https://doi.org/10.1158/1535-7163.c.6530883
https://doi.org/10.1158/1535-7163.c.6530883
Autor:
Patricia V. Schoenlein, John T. Barrett, Sylvia B. Smith, Jim Rawson, Darren Browning, Marlena J. Smith, Manish Shah, Sudharsan Periyasamy Thandavan, Jennifer Duplantier, Virgil T. Gaddy, Julia S. Samaddar
Supplementary Fig. S1 from A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7b5f3d71710b262b3a48d58370340d5
https://doi.org/10.1158/1535-7163.22482279.v1
https://doi.org/10.1158/1535-7163.22482279.v1
Autor:
Patricia V. Schoenlein, John T. Barrett, Sylvia B. Smith, Jim Rawson, Darren Browning, Marlena J. Smith, Manish Shah, Sudharsan Periyasamy Thandavan, Jennifer Duplantier, Virgil T. Gaddy, Julia S. Samaddar
Supplementary Fig. S2 from A role for macroautophagy in protection against 4-hydroxytamoxifen–induced cell death and the development of antiestrogen resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00233b0b89f218fdd58d45449226f3a3
https://doi.org/10.1158/1535-7163.22482276
https://doi.org/10.1158/1535-7163.22482276
Autor:
Julia S. Samaddar, Darren D. Browning, Sudharsan Periyasamy Thandavan, Virgil T. Gaddy, Manish Shah, Jim Rawson, Marlena J. Smith, Patricia V. Schoenlein, Sylvia B. Smith, Jennifer Duplantier, John T. Barrett
Publikováno v:
Molecular Cancer Therapeutics. 7:2977-2987
This study identifies macroautophagy as a key mechanism of cell survival in estrogen receptor–positive (ER+) breast cancer cells undergoing treatment with 4-hydroxytamoxifen (4-OHT). This selective ER modifier is an active metabolite of tamoxifen c
Autor:
Andre M. Kallab, John T. Barrett, Jennifer N. Delk, Patricia V. Schoenlein, Virgil T. Gaddy, Alan George Porter
Publikováno v:
Clinical Cancer Research. 10:5215-5225
Purpose: A major clinical problem in the treatment of breast cancer is the inherent and acquired resistance to antiestrogen therapy. In this study, we sought to determine whether antiprogestin treatment, used as a monotherapy or in combination with a
Autor:
Vadivel Ganapathy, Julia S. Samaddar, Maribeth H. Johnson, Jill B. Lewis, Min Hou, Andre M. Kallab, John T. Barrett, Patricia V. Schoenlein, Muthusamy Thangaraju, Virgil T. Gaddy
Publikováno v:
International Journal of Oncology.
In this study, human MCF-7 breast cancer cells, which express functional estrogen and progesterone receptors, were used to compare the efficacy of combined antiestrogen plus antiprogestin therapy to antiestrogen monotherapy. Cells were treated with t
Autor:
Patricia V, Schoenlein, Min, Hou, Julia S, Samaddar, Virgil T, Gaddy, Muthusamy, Thangaraju, Jill, Lewis, Maribeth, Johnson, Vadivel, Ganapathy, Andre, Kallab, John T, Barrett
Publikováno v:
International journal of oncology. 31(3)
In this study, human MCF-7 breast cancer cells, which express functional estrogen and progesterone receptors, were used to compare the efficacy of combined antiestrogen plus antiprogestin therapy to antiestrogen monotherapy. Cells were treated with t